<p><b>Expression of LAT1 and CD98 in brain metastases and in non-tumoral brain</b>: a) strong and diffuse expression of LAT1 in a BM from small cell lung carcinoma, b) heterogeneous staining of LAT1 in a BM of lung squamous cell carcinoma, c) non-tumoral brain negative for LAT1, d) moderate expression of LAT1 in reactive astrocytes at the periphery of a BM, e) strong membrane expression of CD98 in a BM of lung adenocarcinoma, f) focal expression of CD98 in a BM of a lung squamous cell carcinoma, g) CD98 is only expressed in endothelial cells in non-tumoral brain, h) CD98 expression was rarely detected in reactive astrocytes. Immunohistochemistry, x 200.</p
BackgroundFew data are available on the prevalence and clinicopathological meaning of CD99, the tran...
Background Brain metastasis is a leading cause of cancer mortality and affects 20-40% of all cancer ...
IntroductionThe incidence of brain metastases in cancer patients is increasing, with lung and breast...
Positron emission tomography using radiolabeled amino acid (PET-AA) appears to be promising in disti...
<div><p>Positron emission tomography using radiolabeled amino acid (PET-AA) appears to be promising ...
Background Basal cell carcinoma (BCC) is the most common type of cancer in fair-skinned individuals ...
<div><p>[18F]-FDOPA is a labeled amino acid (AA) analog used for positron emission tomography (PET) ...
The L-Type Amino Acid transporter, LAT1 (SLC7A5), has a crucial role in mediating amino acid uptake ...
The aim of this retrospective study was to evaluate L-type amino acid transporter 1 (LAT1) expressio...
Na+-independent large neutral amino acid transporters (LATs) represent the main intracellular transp...
Background: Dissemination of non-small-cell lung cancer (NSCLC) in the central nervous system is a f...
BACKGROUND: Brain metastases are one of the most malignant complications of lung cancer and constitu...
Expression of system L amino acid transporters (LAT) is strongly increased inmany types of tumor cel...
Background: Few data are available on the prevalence and clinicopathological meaning of CD99, the tr...
Abstract Background LATS1 is a tumor suppressor genes implicated in the pathogenesis of certain type...
BackgroundFew data are available on the prevalence and clinicopathological meaning of CD99, the tran...
Background Brain metastasis is a leading cause of cancer mortality and affects 20-40% of all cancer ...
IntroductionThe incidence of brain metastases in cancer patients is increasing, with lung and breast...
Positron emission tomography using radiolabeled amino acid (PET-AA) appears to be promising in disti...
<div><p>Positron emission tomography using radiolabeled amino acid (PET-AA) appears to be promising ...
Background Basal cell carcinoma (BCC) is the most common type of cancer in fair-skinned individuals ...
<div><p>[18F]-FDOPA is a labeled amino acid (AA) analog used for positron emission tomography (PET) ...
The L-Type Amino Acid transporter, LAT1 (SLC7A5), has a crucial role in mediating amino acid uptake ...
The aim of this retrospective study was to evaluate L-type amino acid transporter 1 (LAT1) expressio...
Na+-independent large neutral amino acid transporters (LATs) represent the main intracellular transp...
Background: Dissemination of non-small-cell lung cancer (NSCLC) in the central nervous system is a f...
BACKGROUND: Brain metastases are one of the most malignant complications of lung cancer and constitu...
Expression of system L amino acid transporters (LAT) is strongly increased inmany types of tumor cel...
Background: Few data are available on the prevalence and clinicopathological meaning of CD99, the tr...
Abstract Background LATS1 is a tumor suppressor genes implicated in the pathogenesis of certain type...
BackgroundFew data are available on the prevalence and clinicopathological meaning of CD99, the tran...
Background Brain metastasis is a leading cause of cancer mortality and affects 20-40% of all cancer ...
IntroductionThe incidence of brain metastases in cancer patients is increasing, with lung and breast...